April 17, 2025

We Want Your Perspective!

Join our roster of respected specialists and share your clinical perspectives.

Conexiant

April 16, 2025

CONSORT 2025: Setting New Standards for Clinical Trial Reporting

"Readers should not have to infer what was probably done; they should be told explicitly." This principle drives the comprehensive CONSORT 2025 update, with its 7 new checklist items aimed at improving clinical trial transparency.

Conexiant

March 31, 2025

Tariff Threat: Drugs Could Cost U.S. $750M More

New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.

Conexiant

March 27, 2025

Trauma Patients Face Lasting Mental Health Risks

Among 26,958 trauma patients without prior psychiatric diagnoses, 11.3% developed a new mental health condition, which was associated with elevated risks of readmission, suicide, and all-cause mortality.

Conexiant

March 27, 2025

Hypoglycemia Cases Tied to Slush Drinks

A new study identifies glycerol intoxication syndrome in children after consuming slush ice drinks, leading to hypoglycemia, metabolic acidosis, and altered consciousness.

Conexiant

January 16, 2025

Vertigo, Emesis, Auditory Impairment: What's Your Diagnosis?

A patient presents with sudden-onset right-sided otalgia accompanied by vertigo, emesis, and auditory impairment. Your otoscope reveals an unexpected finding. What's your diagnosis?

Conexiant

February 27, 2025

Study Finds EVT Does Not Improve Stroke Recovery

EVT did not confer a functional benefit in patients with medium-vessel occlusion stroke, according to key findings from the ESCAPE-MeVO trial.

Conexiant

February 10, 2025

Research Links mTBI in Trauma to PTSD and Symptoms

Veterans with peritraumatic mTBI reported greater PTSD severity and disability, study finds.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant